4 597

Cited 25 times in

Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy

Authors
 Yun Jin Lee  ;  Hoon-Chul Kang  ;  Heung Dong Kim  ;  Joon Soo Lee 
Citation
 PEDIATRIC NEUROLOGY, Vol.42(2) : 86-92, 2010 
Journal Title
PEDIATRIC NEUROLOGY
ISSN
 0887-8994 
Issue Date
2010
MeSH
Adolescent ; Age Factors ; Aggression/drug effects ; Aggression/physiology ; Aggression/psychology ; Child ; Child, Preschool ; Epilepsy/drug therapy* ; Epilepsy/physiopathology ; Epilepsy/psychology ; Female ; Humans ; Infant ; Irritable Mood/drug effects ; Irritable Mood/physiology ; Male ; Piracetam/adverse effects ; Piracetam/analogs & derivatives* ; Piracetam/therapeutic use ; Retrospective Studies ; Treatment Outcome
Abstract
To investigate the efficacy and safety of levetiracetam adjunctive therapy in childhood intractable epilepsy, data were reviewed for 130 children who had >or=4 seizures per month, whose seizures were intractable to an initial >or=2 antiepileptic drugs, and who could be monitored for at least 6 months after levetiracetam add-on. Reduction in seizure frequency and related variables were investigated. Sixty-two of the 130 patients (48%) showed a seizure reduction of >or=50%, and 28 patients (22%) became seizure-free. A reduction in seizures by >or=50% was observed in 33/64 in children with partial seizures (52%) and in 29/66 children with generalized seizures (44%). Efficacy did not differ significantly among seizure types. Overall efficacy was unaffected by abnormalities evident from magnetic resonance imaging, by mental retardation, or by maintenance dose of levetiracetam. The mean maintenance dose of levetiracetam was 47.0mg/kg per day (S.D. = +/- 29.7), and mean follow-up duration was 13.4 months (S.D. =+/- 8.7). No demographic features differed significantly between patients with seizure freedom and without seizure remission. Levetiracetam was discontinued in 24 children at last visit (retention rate, 82%). The most common complaint was irritability (5%), and none of the adverse events were life threatening. In conclusion, levetiracetam adjunctive therapy is effective and safe for childhood intractable epilepsy
Full Text
http://www.sciencedirect.com/science/article/pii/S0887899409003919
DOI
10.1016/j.pediatrneurol.2009.08.002
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Hoon Chul(강훈철) ORCID logo https://orcid.org/0000-0002-3659-8847
Kim, Heung Dong(김흥동) ORCID logo https://orcid.org/0000-0002-8031-7336
Lee, Yun Jin(이윤진)
Lee, Joon Soo(이준수) ORCID logo https://orcid.org/0000-0001-9036-9343
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/100533
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links